Annual report pursuant to Section 13 and 15(d)

Notes Payable (Details Narrative)

v3.22.1
Notes Payable (Details Narrative) - Bridge Loan Note [Member] - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Nov. 11, 2020
MyMD Pharmaceuticals (Florida), Inc [Member]      
Short-term Debt [Line Items]      
Advances to affiliate $ 3,000,000 $ 1,200,000  
Interest receivable 26,137    
Related party receivable $ 3,026,137    
Merger Agreement [Member]      
Short-term Debt [Line Items]      
Maximum principal amount     $ 3,000,000
Interest rate     5.00%
Merger Agreement [Member] | Event of Default [Member]      
Short-term Debt [Line Items]      
Interest rate     8.00%